Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Molecular Ecology Resources
|
May 14, 2011
Isolation and characterization of 23 polymorphic microsatellite loci for a West Indian iguana (Cyclura pinguis) from the British Virgin Islands
Jennie Lau, Allison C Alberts, Leona G Chemnick, et al.
Annals of Clinical and Translational Neurology
|
July 24, 2024
ALS Identified: two-year findings from a sponsored ALS genetic testing program
Stephen A Goutman, Namita A Goyal, Katelyn Payne, et al.
Inflammatory Bowel Diseases
|
February 25, 2009
FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease
Juan L Mendoza, Raquel Lana, Maria C Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 30, 2010
Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia
Nutan Sharma, Ramon A Franco, John K Kuster, et al.
Forensic Science International
|
March 18, 2014
Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths
Dawei Wang, Krunal R Shah, Sung Yon Um, et al.
BMC Medical Genetics
|
May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
Inga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Infection and Immunity
|
November 20, 2002
Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection
Theresa M Karplus, Selma M B Jeronimo, Haeok Chang, et al.
American Journal of Human Genetics
|
August 10, 2010
Microdeletions of 3q29 confer high risk for schizophrenia
Jennifer Gladys Mulle, Anne F Dodd, John A McGrath, et al.
American Journal of Human Genetics
|
September 16, 2025
Landscapes of missense variant impact for human superoxide dismutase 1
Anna Axakova, Megan Ding, Atina G Cote, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Molecular Ecology Resources
|
May 14, 2011
Isolation and characterization of 23 polymorphic microsatellite loci for a West Indian iguana (Cyclura pinguis) from the British Virgin Islands
Jennie Lau, Allison C Alberts, Leona G Chemnick, et al.
Annals of Clinical and Translational Neurology
|
July 24, 2024
ALS Identified: two-year findings from a sponsored ALS genetic testing program
Stephen A Goutman, Namita A Goyal, Katelyn Payne, et al.
Inflammatory Bowel Diseases
|
February 25, 2009
FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease
Juan L Mendoza, Raquel Lana, Maria C Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 30, 2010
Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia
Nutan Sharma, Ramon A Franco, John K Kuster, et al.
Forensic Science International
|
March 18, 2014
Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths
Dawei Wang, Krunal R Shah, Sung Yon Um, et al.
BMC Medical Genetics
|
May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
Inga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Infection and Immunity
|
November 20, 2002
Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection
Theresa M Karplus, Selma M B Jeronimo, Haeok Chang, et al.
American Journal of Human Genetics
|
August 10, 2010
Microdeletions of 3q29 confer high risk for schizophrenia
Jennifer Gladys Mulle, Anne F Dodd, John A McGrath, et al.
American Journal of Human Genetics
|
September 16, 2025
Landscapes of missense variant impact for human superoxide dismutase 1
Anna Axakova, Megan Ding, Atina G Cote, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Page
of 3